FDA Brief

Warning letters Food

FDA warning letter to

Schwebel Baking Company

High riskIssued Jun 9, 2023Posted Jun 27, 2023Division of Human and Animal Food Operations East V

FDA warned Schwebel Baking that its Hebron, Ohio ready-to-eat bun plant had sesame allergen cross-contact and pest problems.

What happened

FDA inspected the company's ready-to-eat (RTE, meaning eaten without further cooking) bread roll plant in Hebron, Ohio, from January 30 through February 3, 2023. Investigators saw sesame seeds still on a shared cooler conveyor after a cleaning changeover from sesame to non-sesame buns, found the plant's hazard analysis did not treat allergens or after-baking germs as hazards needing controls, and found four Listeria positive or suspect swabs with no cleaning or retesting recorded. They also saw a live mouse, rodent droppings in warehousing areas, fruit flies too numerous to count in the ingredient pit, and live flour beetles on sugar bags near the mixer; FDA had raised allergen and pest concerns at a 2022 inspection and a September 12, 2022 meeting.

What FDA found

  1. The written hazard analysis did not treat allergen cross-contact on shared equipment as a hazard needing a preventive control, even though 21 bun products with different allergens run on the same lines.

    21 CFR 117.130(a)(1)
  2. The hazard analysis did not treat contamination by germs such as Salmonella and Listeria from the plant environment after baking as a hazard needing a preventive control.

    21 CFR 117.130(a)(1)
  3. Cleaning of the depanner, cooler, metal detector and other equipment was scheduled too rarely and was often not recorded, and no corrective action was taken when cleaning was skipped.

    21 CFR 117.135(a)(1) and 117.140
  4. Four Listeria suspect or confirmed positive environmental results between November 2022 and January 2023 were not followed by recleaning or retesting.

    21 CFR 117.80(c)(2)
  5. Pests were not kept out: a live mouse, rodent droppings, fruit flies and flour beetles were seen in storage and ingredient areas, with pallets spaced too closely to clean and monitor.

    21 CFR 117.35(c)

What FDA wants

FDA asks the company to write back within 15 working days describing each corrective step taken and how it will prevent repeat violations, with supporting records. If a fix cannot be finished in that time, the company must say why and give a completion date.

Who should pay attention

  • brands that buy private-label buns from this bakery
  • retailers and foodservice operators that sell ready-to-eat buns
  • other bakeries running allergen changeovers on shared lines

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Flax & More Corporation

    FDA warned Flax & More Corporation that its dietary supplements were made under conditions that failed required manufacturing quality rules.

    High risk
  2. Dough-To-Go, Inc.

    FDA warned Dough-To-Go of Santa Clara, CA after an inspection found insanitary conditions and unused food safety controls at its baked goods plant.

    High risk
  3. Aversa's Italian Bakery

    FDA warns Aversa's Italian Bakery over missing food safety plan and undeclared sesame/milk allergens in ready-to-eat rolls.

    High risk
  4. RSV Pita, Inc. DBA Pita Pan Bakery

    FDA warns Pita Pan Bakery that ready-to-eat pita, bagels and challah were made under insanitary conditions and had undeclared allergens.

    High risk